Details of the Drug

General Information of Drug (ID: DMO6U80)

• Drug Name: GSK2321138A

Indication

Disease Entry	ICD 11	Status	REF
Influenza virus infection	1E30-1E32	Phase 3	[1]

• Cross-matching ID: TTD ID: D00JZD

References

• [1] ClinicalTrials.gov (NCT01439360) An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children. U.S. National Institutes of Health.